Pacific Short Term Investments vs Property Plant And Equipment Net Analysis

PACB Stock  USD 2.08  0.25  13.66%   
Pacific Biosciences financial indicator trend analysis is much more than just breaking down Pacific Biosciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pacific Biosciences is a good investment. Please check the relationship between Pacific Biosciences Short Term Investments and its Property Plant And Equipment Net accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacific Biosciences of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Short Term Investments vs Property Plant And Equipment Net

Short Term Investments vs Property Plant And Equipment Net Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pacific Biosciences Short Term Investments account and Property Plant And Equipment Net. At this time, the significance of the direction appears to have strong relationship.
The correlation between Pacific Biosciences' Short Term Investments and Property Plant And Equipment Net is 0.73. Overlapping area represents the amount of variation of Short Term Investments that can explain the historical movement of Property Plant And Equipment Net in the same time period over historical financial statements of Pacific Biosciences of, assuming nothing else is changed. The correlation between historical values of Pacific Biosciences' Short Term Investments and Property Plant And Equipment Net is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Term Investments of Pacific Biosciences of are associated (or correlated) with its Property Plant And Equipment Net. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Property Plant And Equipment Net has no effect on the direction of Short Term Investments i.e., Pacific Biosciences' Short Term Investments and Property Plant And Equipment Net go up and down completely randomly.

Correlation Coefficient

0.73
Relationship DirectionPositive 
Relationship StrengthSignificant

Short Term Investments

Short Term Investments is an item under the current assets section of Pacific Biosciences balance sheet. It contains any investments Pacific Biosciences of undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Pacific Biosciences can easily liquidate in the marketplace.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.
Most indicators from Pacific Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pacific Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacific Biosciences of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
The current year's Selling General Administrative is expected to grow to about 177.3 M, whereas Tax Provision is forecasted to decline to (11.2 M).
 2021 2022 2023 2024 (projected)
Gross Profit58.9M49.0M52.8M28.1M
Total Revenue130.5M128.3M200.5M210.5M

Pacific Biosciences fundamental ratios Correlations

0.870.870.60.910.890.220.820.590.82-0.970.750.630.880.120.150.790.860.820.910.970.830.950.830.540.93
0.870.990.710.960.970.450.730.770.93-0.820.710.750.990.09-0.090.970.980.990.890.890.990.860.980.340.95
0.870.990.730.960.940.390.710.750.96-0.840.740.691.00.13-0.140.940.960.990.90.890.990.870.960.380.95
0.60.710.730.640.620.040.590.690.68-0.590.520.590.710.340.150.690.680.750.580.590.750.50.70.440.65
0.910.960.960.640.960.340.670.70.93-0.90.740.640.970.16-0.040.90.940.920.930.950.930.90.920.410.94
0.890.970.940.620.960.460.730.720.86-0.840.680.760.950.050.00.950.980.910.890.910.920.870.960.290.93
0.220.450.390.040.340.460.390.640.24-0.120.240.640.35-0.2-0.160.60.520.430.080.250.430.130.570.020.3
0.820.730.710.590.670.730.390.660.59-0.760.770.770.70.010.220.740.730.710.620.750.710.710.750.610.77
0.590.770.750.690.70.720.640.660.62-0.560.580.810.710.260.090.840.780.780.460.640.770.430.830.390.62
0.820.930.960.680.930.860.240.590.62-0.830.740.470.970.16-0.310.830.860.940.90.860.940.870.850.350.93
-0.97-0.82-0.84-0.59-0.9-0.84-0.12-0.76-0.56-0.83-0.8-0.5-0.86-0.22-0.1-0.72-0.79-0.77-0.89-0.96-0.78-0.93-0.75-0.55-0.91
0.750.710.740.520.740.680.240.770.580.74-0.80.440.730.34-0.070.630.640.70.640.780.710.710.660.650.79
0.630.750.690.590.640.760.640.770.810.47-0.50.440.66-0.010.350.870.820.720.50.60.720.50.850.280.61
0.880.991.00.710.970.950.350.70.710.97-0.860.730.660.12-0.150.920.950.980.920.90.980.90.940.360.96
0.120.090.130.340.160.05-0.20.010.260.16-0.220.34-0.010.120.370.030.040.110.010.20.120.00.060.360.1
0.15-0.09-0.140.15-0.040.0-0.160.220.09-0.31-0.1-0.070.35-0.150.37-0.020.01-0.15-0.080.08-0.14-0.06-0.020.29-0.12
0.790.970.940.690.90.950.60.740.840.83-0.720.630.870.920.03-0.020.990.950.770.810.950.741.00.30.87
0.860.980.960.680.940.980.520.730.780.86-0.790.640.820.950.040.010.990.950.850.870.950.820.990.290.91
0.820.990.990.750.920.910.430.710.780.94-0.770.70.720.980.11-0.150.950.950.850.841.00.810.960.360.92
0.910.890.90.580.930.890.080.620.460.9-0.890.640.50.920.01-0.080.770.850.850.90.860.970.810.30.92
0.970.890.890.590.950.910.250.750.640.86-0.960.780.60.90.20.080.810.870.840.90.850.930.840.50.93
0.830.990.990.750.930.920.430.710.770.94-0.780.710.720.980.12-0.140.950.951.00.860.850.820.960.370.93
0.950.860.870.50.90.870.130.710.430.87-0.930.710.50.90.0-0.060.740.820.810.970.930.820.780.390.94
0.830.980.960.70.920.960.570.750.830.85-0.750.660.850.940.06-0.021.00.990.960.810.840.960.780.320.89
0.540.340.380.440.410.290.020.610.390.35-0.550.650.280.360.360.290.30.290.360.30.50.370.390.320.39
0.930.950.950.650.940.930.30.770.620.93-0.910.790.610.960.1-0.120.870.910.920.920.930.930.940.890.39
Click cells to compare fundamentals

Pacific Biosciences Account Relationship Matchups

Pacific Biosciences fundamental ratios Accounts

201920202021202220232024 (projected)
Common Stock Shares Outstanding152.5M175.0M204.1M224.6M253.6M266.3M
Total Assets148.0M414.0M2.0B1.8B1.7B1.8B
Short Long Term Debt Total61.7M42.0M953.7M957.4M933.9M980.6M
Other Current Liab(13.9M)17.5M40.4M201.2M53.5M56.2M
Total Current Liabilities21.8M36.5M83.3M76.9M95.0M99.8M
Total Stockholder Equity54.9M335.5M791.0M562.9M701.3M736.4M
Other Liab2.0M10.3M215.0M2.6M3.0M2.8M
Property Plant And Equipment Net62.9M54.9M79.1M81.3M69.0M35.5M
Current Deferred Revenue7.6M10.3M36.0M32.3M16.3M13.1M
Net Debt12.6M(276.8M)493.0M632.3M754.0M791.7M
Retained Earnings(1.1B)(1.0B)(1.2B)(1.5B)(1.8B)(1.7B)
Accounts Payable8.4M3.6M11.0M12.0M15.1M7.6M
Cash49.1M318.8M460.7M325.1M179.9M137.4M
Non Current Assets Total66.9M59.2M901.2M912.1M1.0B1.1B
Non Currrent Assets Other42K879K1.2M10.5M3.7M3.7M
Other Assets4.0M33.5M1.2M13.5M1.00.95
Cash And Short Term Investments49.1M318.8M1.0B772.3M631.4M663.0M
Short Term Investments19.5M237.2M583.7M447.2M451.5M474.1M
Liabilities And Stockholders Equity148.0M414.0M2.0B1.8B1.7B1.8B
Non Current Liabilities Total71.2M42.0M1.1B1.1B949.7M997.2M
Other Current Assets3.4M5.7M7.9M10.6M17.3M18.2M
Other Stockholder Equity1.1B1.4B2.0B2.1B2.5B2.7B
Total Liab93.1M78.5M1.2B1.2B1.0B1.1B
Property Plant And Equipment Gross62.9M54.9M79.1M81.3M143.8M151.0M
Total Current Assets81.0M354.8M1.1B855.0M742.0M779.1M
Short Term Debt19.7M8.7M9.3M19.6M10.1M8.2M
Property Plant Equipment30.1M24.9M79.1M81.3M93.5M98.2M
Long Term Debt14.7M15.9M896.1M896.7M892.2M936.9M
Net Receivables15.3M16.8M24.2M18.8M36.6M38.4M
Common Stock Total Equity150K153K192K221K198.9K189.0K
Inventory13.3M14.2M24.6M50.4M56.7M59.5M
Common Stock153K192K221K227K268K254.6K
Net Tangible Assets54.9M335.5M(30.0M)(257.3M)(231.6M)(220.0M)
Retained Earnings Total Equity(982.1M)(1.1B)(1.0B)(1.2B)(1.1B)(1.2B)
Capital Surpluse1.1B1.1B1.4B2.0B2.3B1.2B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Pacific Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pacific Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pacific Biosciences Of Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pacific Biosciences Of Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacific Biosciences of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacific Biosciences. If investors know Pacific will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pacific Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.46)
Revenue Per Share
0.64
Quarterly Revenue Growth
(0.28)
Return On Assets
(0.11)
Return On Equity
(0.65)
The market value of Pacific Biosciences is measured differently than its book value, which is the value of Pacific that is recorded on the company's balance sheet. Investors also form their own opinion of Pacific Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Pacific Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pacific Biosciences' market value can be influenced by many factors that don't directly affect Pacific Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pacific Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pacific Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pacific Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.